Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sartorius Stedim Bio    DIM   FR0000053266

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in  € Estimates in  €
Fiscal Period December 201220132014201520162017
Sales544588-748821888
Operating income (EBITDA)119136-182210236
Operating profit (EBIT)87,2--149174199
Pre-Tax Profit (EBT)---146170194
Net income57,967,587,2101118138
EPS ( €)3,704,905,686,457,518,96
Dividend per Share ( €)1,101,20-1,491,851,75
Yield0,56%0,61%-0,76%0,94%0,89%
Announcement Date01/29/2013
08:59am
01/28/2014
06:00am
----
Finances - Leverage
Actuals in  € Estimates in  €
Fiscal Period December 201220132014201520162017
Debt116--46,2--
Finance----6,1098,0
Operating income (EBITDA)119136-182210236
Leverage
(Debt/EBITDA)
0,98x--0,25x--
Capital Expenditure38,829,3-61,158,554,5
Book Value Per Share (BVPS)28,2 €--36,5 €45,0 €53,0 €
Cash Flow per Share2,87 €--8,20 €9,86 €10,5 €
Announcement Date01/29/2013
08:59am
01/28/2014
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 3 018 M€ -
Entreprise Value (EV) 3 064 M€ 3 012 M€
Valuation 2015e 2016e
PER (Price / EPS) 30,5x 26,2x
Capitalization / Revenue 4,04x 3,68x
EV / Revenue 4,10x 3,67x
EV / EBITDA 16,8x 14,3x
Yield (DPS / Price) 0,76% 0,94%
Price to book (Price / BVPS) 5,39x 4,37x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 19,9% 21,2%
operating Leverage (Delta EBIT / Delta Sales) - 1,72x
Net Margin (Net Profit / Revenue) 13,5% 14,3%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 17,3% 17,4%
Rate of Dividend 23,1% 24,6%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,17% 7,12%
Cash Flow / Sales (Taux d'autofinancement) 16,8% 18,4%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,25x -0,03x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF